Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-17

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Dexmethylphenidate hydrochloride (Amneal) to approve a generic version of the ADHD medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE (dexmethylphenidate hydrochloride)

Snippet

SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)